PL4021929T3 - Analogi ham15-52 z poprawioną siłą działania receptora amyliny (hamy3r) - Google Patents
Analogi ham15-52 z poprawioną siłą działania receptora amyliny (hamy3r)Info
- Publication number
- PL4021929T3 PL4021929T3 PL21782735.1T PL21782735T PL4021929T3 PL 4021929 T3 PL4021929 T3 PL 4021929T3 PL 21782735 T PL21782735 T PL 21782735T PL 4021929 T3 PL4021929 T3 PL 4021929T3
- Authority
- PL
- Poland
- Prior art keywords
- hamy3r
- ham15
- potency
- analogues
- improved
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Endocrinology (AREA)
- Diabetes (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Zoology (AREA)
- Toxicology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Hematology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Obesity (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Emergency Medicine (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP20198117 | 2020-09-24 | ||
| PCT/EP2021/076250 WO2022063925A1 (en) | 2020-09-24 | 2021-09-23 | Ham15-52 analogues with improved amylin receptor (hamy3r) potency |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL4021929T3 true PL4021929T3 (pl) | 2023-07-31 |
Family
ID=72659001
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL21782735.1T PL4021929T3 (pl) | 2020-09-24 | 2021-09-23 | Analogi ham15-52 z poprawioną siłą działania receptora amyliny (hamy3r) |
Country Status (21)
| Country | Link |
|---|---|
| US (2) | US12139520B2 (pl) |
| EP (1) | EP4021929B1 (pl) |
| JP (1) | JP2023544959A (pl) |
| KR (1) | KR20230073176A (pl) |
| CN (1) | CN116322741A (pl) |
| AU (1) | AU2021350396A1 (pl) |
| BR (1) | BR112023002525A2 (pl) |
| CA (1) | CA3189267A1 (pl) |
| DK (1) | DK4021929T5 (pl) |
| ES (1) | ES2950137T3 (pl) |
| FI (1) | FI4021929T3 (pl) |
| HR (1) | HRP20230534T1 (pl) |
| HU (1) | HUE062560T2 (pl) |
| IL (1) | IL300620B2 (pl) |
| MX (1) | MX2023002182A (pl) |
| PL (1) | PL4021929T3 (pl) |
| PT (1) | PT4021929T (pl) |
| RS (1) | RS64256B1 (pl) |
| SI (1) | SI4021929T1 (pl) |
| WO (1) | WO2022063925A1 (pl) |
| ZA (1) | ZA202301635B (pl) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TW202400632A (zh) | 2021-03-03 | 2024-01-01 | 美商美國禮來大藥廠 | 長效澱粉素受體促效劑及其用途 |
| CA3258970A1 (en) | 2022-07-01 | 2024-01-04 | Gubra A/S | AMYLIN RECEPTOR AGONISTS (HAMY3R) WITH IMPROVED CHEMICAL STABILITY |
| WO2025114501A1 (en) | 2023-11-30 | 2025-06-05 | Novo Nordisk A/S | Tri-agonists of the glp-1, gip, and amylin receptors |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5288931A (en) * | 1991-12-06 | 1994-02-22 | Genentech, Inc. | Method for refolding insoluble, misfolded insulin-like growth factor-I into an active conformation |
| GB9912350D0 (en) * | 1999-05-26 | 1999-07-28 | European Molecular Biology Lab Embl | Modified cytokine |
| FI117667B (fi) * | 2001-07-05 | 2007-01-15 | Univ Zuerich | Farmaseuttinen koostumus, joka soveltuu käytettäväksi ortopediassa ja hammaslääketieteessä |
| US20060094652A1 (en) * | 2004-02-11 | 2006-05-04 | Levy Odile E | Hybrid polypeptides with selectable properties |
| AU2006279680B2 (en) | 2005-08-11 | 2012-12-06 | Amylin Pharmaceuticals, Llc | Hybrid polypeptides with selectable properties |
| JP6161541B2 (ja) * | 2011-02-03 | 2017-07-12 | ゾーマ テクノロジー リミテッド | 細菌中の機能的タンパク質発現を向上させるための方法および物質 |
| KR102066987B1 (ko) | 2011-06-10 | 2020-01-16 | 노보 노르디스크 에이/에스 | 폴리펩티드 |
| AR097701A1 (es) * | 2013-09-19 | 2016-04-13 | Zealand Pharma As | Análogos de amilina |
| EA035791B1 (ru) * | 2015-03-18 | 2020-08-11 | Зилэнд Фарма А/С | Аналоги амилина |
| EP3645031A4 (en) | 2017-06-30 | 2021-03-31 | Adepthera LLC | PEPTIDIC ANALOGUES |
| KR102911883B1 (ko) * | 2018-10-11 | 2026-01-13 | 인타르시아 세라퓨틱스 인코포레이티드 | 인간 아밀린 유사체 폴리펩타이드 및 사용 방법 |
-
2021
- 2021-09-23 IL IL300620A patent/IL300620B2/en unknown
- 2021-09-23 CN CN202180056599.9A patent/CN116322741A/zh active Pending
- 2021-09-23 US US18/024,879 patent/US12139520B2/en active Active
- 2021-09-23 JP JP2023510390A patent/JP2023544959A/ja active Pending
- 2021-09-23 KR KR1020237005061A patent/KR20230073176A/ko active Pending
- 2021-09-23 EP EP21782735.1A patent/EP4021929B1/en active Active
- 2021-09-23 CA CA3189267A patent/CA3189267A1/en active Pending
- 2021-09-23 HR HRP20230534TT patent/HRP20230534T1/hr unknown
- 2021-09-23 PL PL21782735.1T patent/PL4021929T3/pl unknown
- 2021-09-23 ES ES21782735T patent/ES2950137T3/es active Active
- 2021-09-23 MX MX2023002182A patent/MX2023002182A/es unknown
- 2021-09-23 DK DK21782735.1T patent/DK4021929T5/da active
- 2021-09-23 HU HUE21782735A patent/HUE062560T2/hu unknown
- 2021-09-23 BR BR112023002525A patent/BR112023002525A2/pt unknown
- 2021-09-23 FI FIEP21782735.1T patent/FI4021929T3/fi active
- 2021-09-23 SI SI202130047T patent/SI4021929T1/sl unknown
- 2021-09-23 RS RS20230442A patent/RS64256B1/sr unknown
- 2021-09-23 PT PT217827351T patent/PT4021929T/pt unknown
- 2021-09-23 AU AU2021350396A patent/AU2021350396A1/en active Pending
- 2021-09-23 WO PCT/EP2021/076250 patent/WO2022063925A1/en not_active Ceased
-
2023
- 2023-02-09 ZA ZA2023/01635A patent/ZA202301635B/en unknown
-
2024
- 2024-10-10 US US18/911,605 patent/US20250129134A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| JP2023544959A (ja) | 2023-10-26 |
| IL300620A (en) | 2023-04-01 |
| EP4021929A1 (en) | 2022-07-06 |
| PT4021929T (pt) | 2023-06-21 |
| AU2021350396A1 (en) | 2023-03-16 |
| US20240101634A1 (en) | 2024-03-28 |
| SI4021929T1 (sl) | 2023-09-29 |
| RS64256B1 (sr) | 2023-07-31 |
| FI4021929T3 (fi) | 2023-06-14 |
| WO2022063925A1 (en) | 2022-03-31 |
| HUE062560T2 (hu) | 2023-11-28 |
| ES2950137T3 (es) | 2023-10-05 |
| DK4021929T3 (da) | 2023-07-10 |
| CA3189267A1 (en) | 2022-03-31 |
| IL300620B1 (en) | 2025-08-01 |
| MX2023002182A (es) | 2023-11-16 |
| KR20230073176A (ko) | 2023-05-25 |
| ZA202301635B (en) | 2024-03-27 |
| US20250129134A1 (en) | 2025-04-24 |
| US12139520B2 (en) | 2024-11-12 |
| DK4021929T5 (da) | 2024-07-29 |
| HRP20230534T1 (hr) | 2023-08-04 |
| EP4021929B1 (en) | 2023-04-26 |
| IL300620B2 (en) | 2025-12-01 |
| BR112023002525A2 (pt) | 2023-04-04 |
| CN116322741A (zh) | 2023-06-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SI4021929T1 (sl) | Analogi HAM15-52 z izboljšano močjo receptorja za amilin(HAMY3R) | |
| HUE070634T2 (hu) | GLP-1 receptor agonista | |
| IL277483A (en) | New anti-GLP-1 analogs | |
| PL4214120T3 (pl) | Konstrukcja statku powietrznego | |
| PL4301770T3 (pl) | Długodziałający agoniści receptora amyliny i ich zastosowania | |
| GB202217541D0 (en) | Recombinant receptor | |
| GB202509777D0 (en) | Amylin analogues | |
| GB202007106D0 (en) | Cyclosporine analogues | |
| GB202011604D0 (en) | GLP-1 receptor antagonists | |
| DK4448956T3 (en) | Lightning receptor assembly | |
| GB2610694B (en) | Picking station | |
| GB202116270D0 (en) | Ergoline analogues | |
| CA3273860A1 (en) | Amylin analogues | |
| HK40130116A (en) | Amylin analogues | |
| GB202210431D0 (en) | Ergoline analogues | |
| GB202107104D0 (en) | Ergoline analogues | |
| GB202100549D0 (en) | Ergoline Analogues | |
| GB201903900D0 (en) | Adenosine receptor agonists | |
| GB202317191D0 (en) | Analogues | |
| GB202317193D0 (en) | Analogues | |
| IL317600A (en) | Amylin receptor (HAMY3R) agonists with improved chemical stability | |
| GB202210436D0 (en) | Tryptamine analogues | |
| HK40128917A (zh) | 具有多种生长抑素受体亚型选择性的卤化生长抑素类似物 | |
| CA218450S (en) | Aircraft | |
| CA3275750A1 (en) | Amylin receptor agonists |